首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Conformationally restrained analogues of sympathomimetic catecholamines. Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro(naphthalen-1(2H)-2',5'-morpholines).
【24h】

Conformationally restrained analogues of sympathomimetic catecholamines. Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro(naphthalen-1(2H)-2',5'-morpholines).

机译:拟交感神经儿茶酚胺的构象受限类似物。 5,6-和6,7-二羟基-3,4-二氢螺(萘-1(2H)-2',5'-吗啉)的合成和肾上腺素活性。

获取原文
获取原文并翻译 | 示例
           

摘要

The 5,6- (10a) and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-)-2',5'-morpholine](11a) and their N-isopropyl derivatives (10b and 11b) (DDSNMs), which can be viewed as the result of the combination of the structure of the 2-(3,4-dihydroxyphenyl)morpholine 5a or 5b (DPMs) with the structure of the corresponding 1-(aminomethyl)-5,6-dihydroxy- (8a or 8b) or 1-(aminomethyl)-6,7-dihydroxy-1,2,3,4-tetrahydro-1-naphthalen-ol (9a or 9b) (1-AMDTNs) were synthesised. The new compounds DDSNMs 10a,b and 11a,b were assayed for their alpha- and beta-adrenergic properties by means of binding experiments and functional tests and the results were compared with those obtained for catecholamines 1a, b and the previously described morpholine (5) and tetrahydronaphthalene (8, 9) derivatives. The affinity and activity indices thus obtained indicate in general a low ability of the new compounds 10 and 11 to interact with the alpha- and beta-adrenoceptors, which, in all cases, was lower than that of the corresponding morpholine (5) and tetrahydronaphthalene (8, 9) analogues.
机译:5,6-(10a)和6,7-二羟基-3,4-二氢螺[萘-1(2H)-)-2',5'-吗啉](11a)及其N-异丙基衍生物(10b和11b)(DDSNMs),可以看作是2-(3,4-二羟基苯基)吗啉5a或5b(DPMs)结构与相应的1-(氨基甲基)-5结构结合的结果合成了6-6-二羟基-(8a或8b)或1-(氨基甲基)-6,7-二羟基-1,2,3,4-四氢-1-萘酚(9a或9b)(1-AMDTNs) 。通过结合实验和功能测试分析了新化合物DDSNMs 10a,b和11a,b的α-和β-肾上腺素能,并将结果与​​儿茶酚胺1a,b和先前所述的吗啉进行了比较(5 )和四氢萘(8,9)衍生物。由此获得的亲和力和活性指数通常表明新化合物10和11与α-和β-肾上腺素受体相互作用的能力低,在所有情况下,其均低于相应的吗啉(5)和四氢萘的能力。 (8,9)类似物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号